86,762 verified 4-option questions Double-checked by independent solution

NCLEX-RN · Psychosocial Integrity · 7 min read

Substance Use, Withdrawal and Overdose

In this lesson you will
  • Differentiate tolerance, physical dependence, and psychological dependence, and apply screening tools and communication techniques for substance use disorders.
  • Analyze the progression, potential complications, environmental needs, and pharmacologic management of acute alcohol withdrawal.
  • Prioritize nursing interventions for acute opioid overdose and contrast the clinical features and management of opioid withdrawal.

Foundations of Substance Use Disorders, Dynamics, and Screening

Substance use disorder is defined as a problematic pattern of substance use that causes clinically significant impairment or distress. Individuals living with this condition often demonstrate continued substance use despite experiencing adverse personal, social, occupational, or physical consequences. In clinical practice, understanding the physiological and behavioral adaptations associated with substance use is critical. Tolerance develops when repeated use of a substance diminishes its biological effect, which means an individual requires a larger dose over time to achieve the original effect. Physical dependence is distinct from tolerance; it is characterized by the emergence of physiological withdrawal symptoms whenever the substance is abruptly reduced or discontinued. In contrast, psychological dependence involves an emotional and mental craving for the substance's effects to sustain a subjective sense of well-being.

Maladaptive coping mechanisms and interpersonal patterns frequently accompany substance use disorders. Individuals commonly rely on denial and rationalization as unconscious defense mechanisms to minimize, justify, or obscure the reality and impact of their substance use. Family members and close contacts may develop codependency, a relationship pattern in which a person becomes excessively focused on another person's needs. This excessive focus often leads to enabling behaviors that shield the individual from the natural consequences of their addiction. Common enabling behaviors include making excuses for missed responsibilities, paying off debts incurred through substance use, or directly intervening to prevent legal or occupational repercussions. Furthermore, nurses frequently encounter dual diagnosis, which refers to the simultaneous co-occurrence of a substance use disorder and a psychiatric mental health disorder, requiring integrated assessment and comprehensive support.

Early identification and supportive engagement are pivotal in healthcare settings. The CAGE questionnaire is an efficient, four-item screening tool used in clinical settings to assess potential alcohol use disorder. The acronym represents four specific inquiries: whether the individual has ever felt the need to Cut down on drinking, felt Annoyed by criticism of their drinking, felt Guilty about drinking, or ever taken a drink first thing in the morning as an Eye-opener to steady nerves or relieve a hangover. A score of two or more affirmative answers constitutes a positive screen. A positive screen warrants further comprehensive clinical assessment for alcohol use disorder, though the score alone is not diagnostic. When communicating with individuals about their substance use, nurses utilize motivational interviewing. This client-centered, non-confrontational counseling approach is designed to help clients explore and resolve ambivalence, thereby facilitating positive behavioral change.

Exam tip. Do not treat a positive CAGE questionnaire score (two or more 'yes' answers) as a definitive medical diagnosis. On the NCLEX, a positive screen is an assessment trigger that indicates the nurse must conduct or facilitate further clinical evaluation.

Common mistakes

  • Withholding urgently needed dextrose from a hypoglycemic patient because thiamine is not immediately on hand, rather than recognizing that life-threatening hypoglycemia requires immediate correction.
  • Assuming that a score of two or more on the CAGE questionnaire confirms a medical diagnosis of alcohol use disorder, rather than understanding it is a positive screening tool that warrants further clinical assessment.
  • Prematurely discontinuing respiratory monitoring after administering naloxone once the client awakens, overlooking that the opioid's duration of action may outlast naloxone and lead to recurrent respiratory depression.
  • Administering buprenorphine too early after the use of a full opioid agonist, which displaces the agonist from receptors and precipitates severe acute withdrawal.

Key points

  • Tolerance requires increasing doses to achieve the same effect, physical dependence results in physiological withdrawal upon abrupt cessation, and psychological dependence manifests as intense mental cravings.
  • Alcohol withdrawal begins around 6 hours post-cessation with autonomic hyperactivity, can progress to tonic-clonic seizures within 12 to 48 hours, and may culminate in life-threatening delirium tremens between 48 and 96 hours.
  • Benzodiazepines (lorazepam, diazepam, chlordiazepoxide) are first-line for acute alcohol withdrawal by enhancing GABA activity, while thiamine administration prevents Wernicke encephalopathy and Korsakoff syndrome.
  • Long-term alcohol maintenance utilizes disulfiram (aldehyde dehydrogenase inhibitor causing illness if ethanol is consumed), naltrexone (blocks opioid receptors to blunt cravings), and acamprosate (modulates glutamate).
  • Opioid overdose presents with CNS depression, pinpoint pupils (which may dilate if profound hypoxia occurs), and respiratory depression; airway and assisted ventilation are the initial priorities before administering naloxone.
  • Naloxone is a pure antagonist with a shorter duration of action than many opioids, requiring continuous monitoring for recurrent respiratory depression and anticipated acute withdrawal signs.
  • Uncomplicated opioid withdrawal is distressing but rarely life-threatening; treatment options include clonidine for autonomic symptoms and methadone or buprenorphine for opioid use disorder, with standard buprenorphine induction begun after clinically significant withdrawal develops and supervised low-dose initiation available in some settings.

Practice this section

Explained NCLEX Psychosocial Integrity questions, no account needed. NCLEX Psychosocial Integrity practice test

Study guide included with NCLEX plans

The full lesson continues with 4 more sections with exam tips, audio in English and Spanish, 5 Check yourself questions and 20 flashcards.

  • 1 month$58.99 $29.49
  • 3 months$173.99 $86.99
  • Lifetime$350.99 $175.49

One payment, no subscription.

See NCLEX plans

Already a member? Log in

Sample lesson: Therapeutic Communication and Professional Boundaries

25 practice questions on this exam

Each NCLEX practice test has 25 original questions with the answers explained. No account needed.

Open the NCLEX practice tests
All NCLEX-RN lessons

Original lesson written for NCLEX-RN practice · updated October 15, 2026. Exam names are trademarks of their owners; tests.global is not affiliated with them.